share_log

前日に動いた銘柄 part2 エヌエフHD、リベルタ、室町ケミカルなど

Stocks that moved the previous day part 2: NF HD, Liberta, Muromachi Chemical ETC.

Fisco Japan ·  Jan 8 06:32

Stock Name Closing Price on Day 7 ⇒ Comparison with Previous Day

Irex <9517> 739 -20

There is a sense of a cycle in the rapid rebound.

K&O Energy Group <1663> 3720 -60

Sell orders are gathered in Perovskite-related stocks on the 7th.

Kawasaki Kisen <9107> 2229 -62.5

In the strong-moving Marine Shipping stocks on the 6th, profit-taking sales are predominant.

Renova <9519> 768 -29

Strong movements were notably seen in renewable energy-related sectors leading up to the 6th.

ACCESS <4813> 906 -27

Although it saw a significant rise on the 6th, there was a sell-off at the 25-day moving average level.

Technisco <2962> 333 +80

Nothing noteworthy, just some speculative movements.

NF HD <6864> 1530 +300

Interest is turning towards Quantum Computing related fields.

Liberta <4935> 6390 +1000

The movements for short-term profit taking continue due to speculation.

Japan Rad <4736> 1010 +150

Movement for profit taking is seen in Quantum Computing related fields.

Muromachi Chemical <4885> 1131 +150

Being bought as part of measures related to 'PFAS'.

J.E.T <6228> 1440 +229

Riding the wave of rising Semiconductor related Stocks.

Metaplanet <3350> 3775 +200

Taking note of the rise in Bitcoin prices.

REVOLUTION <8894> 380 +29

Aiming for a rebound from the feeling of adjustment coming to an end.

Daiichi Pan <2215> 633 +66

Appears to have been featured in some Broadcasting.

FDK <6955> 602 +72

M&A of Fujitsu General stimulated the market.

GFA <8783> 567 +47

After adjusting to the 25-day line, there is a rebound movement.

Iseka <4107> 30250 -2550

The perovskite-related stocks were generally weak on the 7th.

Renascience <4889> 311 +12

Phase 3 trials for melanoma treatment have been approved by Tohoku University Ethics Review Board.

Buying ahead, but resistance is strong.

Rakuoria Pharmaceuticals <4579> 404 +24

A sub-license agreement for the gastric acid secretion inhibitor tegoprazan in Australia and New Zealand.

Sub-license agreement.

Modalis <4883> 103 -6

JCR Pharma <4552> became popular on the 6th due to a joint research contract, but there was a long upper shadow.

On the 7th, selling is dominant.

CANBAS <4575> 929 +42

免疫系抗がん剤候補化合物CBT005に関し米国で特許査定。

247<7074> 351 -53

The reactionary decline from the limit high on the 6th.

Jiban Network HD <6072> 190 +1

一般社団法人ハウスワランティの「地盤調査・解析・保証及び各種

コンサルタント等」事業を取得。

Skymark <9204> 624 +22

Sojitz is expected to acquire 5% of the stocks and become a major shareholder, purchased on the 6th. Remains strong on the 7th.

Headwater <4011> 5640 +20

Started offering AI agent solutions.

Although it was temporarily bought, the upper prices are heavy.

Kauris <153A> 1468 +67

Officially released the 'Fraud Alert Deposit and Withdrawal Detection' service that monitors deposits and withdrawals.

Official release.

Kaiomu <4583> 263 -6

Joint research results related to antibody technology with the University of Tokyo were presented at a U.S. academic conference.

It starts rising but then loses momentum.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment